Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$4.69
At close: May 27 EDT
$4.69
0.000.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
Personalis (PSNL) Forecast
NewsEarningsPersonalis (PSNL) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Personalis Stock Price, Quotes and Forecasts | NASDAQ:PSNL | Benzinga
Explore Personalis stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PSNL.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Personalis (PSNL) stock?
You can purchase shares of Personalis (NASDAQ:PSNL) through any online brokerage.
Who are Personalis (PSNL) competitors?
Other companies in Personalis’s space includes: 10x Genomics (NASDAQ:TXG), Codexis (NASDAQ:CDXS), BioLife Solutions (NASDAQ:BLFS), Lifecore Biomedical (NASDAQ:LFCR) and Sotera Health (NASDAQ:SHC).
What is the forecast, or price target, for Personalis (PSNL) stock?
Personalis has a consensus price target of $7.29.
What is the current price for Personalis (PSNL)?
The stock price for Personalis (NASDAQ: PSNL) is $4.69 last updated May 27, 2025 at 4:00 PM EDT.
Does Personalis (PSNL) pay a dividend?
There are no upcoming dividends for Personalis.
When is Personalis (NASDAQ:PSNL) reporting earnings?
Personalis’s Q2 earnings are confirmed for Wednesday, August 6, 2025.
Is Personalis (PSNL) going to split?
There is no upcoming split for Personalis.
What sector and industry does Personalis (PSNL) operate in?
Personalis is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
